Skip to content

Clinical trials

Hemorrhagic Stroke trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhagic Stroke Country / region: China Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20111
20161
20181
20193
20201
20224
20233
20244
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting7
Unknown status6
Completed5
Not yet recruiting3
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Abbott Medical Devices2
Beijing Tiantan Hospital2
Duan Chuanzhi2
Beijing Hospital1
Capital Medical University1
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine1
General Hospital of Shenyang Military Region1
Keuro MedTech1
Nanfang Hospital, Southern Medical University1
Nanjing University of Traditional Chinese Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhagic Stroke22
Ischemic Stroke8
Stroke6
Cerebral Hemorrhage5
Intracranial Hemorrhages3
Anemia2
Atrial Fibrillation2
Coronary Artery Disease2
Hematologic Diseases2
Hemorrhage2

Trials

Showing 76 to 22 of 22. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.